Jungu Bae is R&D Strategy Sr. Specialist of Illimis Therapeutics based in 18, Heolleung-ro 569-gil, Gangnam-gu Seoul, 06376, KR. Previously worked at ImmuneOncia Therapeutics Inc. as a Director of Business Development. Illimis Therapeutics is a Hospitals & Healthcare, Medical Practices company in 18, Heolleung-ro 569-gil, Gangnam-gu Seoul, 06376, KR with 13 employees.
Jungu Bae has 14 years of professional experience, with an average of 3 years per position throughout their career. Their recent employment history shows 1 changes in the past 3 years, with high job stability. they do not have Fortune 500 company experience.
Jungu Bae holds a degree from 京都大学 / Kyoto University, with 14 years since graduation. Their career include experience at a global enterprise.
Illimis Therapeutics is founded in 2021, operates from its headquarter in 18, Heolleung-ro 569-gil, Gangnam-gu Seoul, 06376, KR. The company operates in the Hospitals & Healthcare, Medical Practices sector.
Illimis Therapeutics specializes in Chimeric fusion protein development, Antibody-induced neuroinflammation management, ARIA prevention, TAM receptor utilization, Glial cell research, and offers services including Chimeric fusion protein platform, Neurodegenerative disease treatment.
Jungu Bae completed at 京都大学 / Kyoto University (2010 - 2012) , at 広島大学 / Hiroshima University (2006 - 2010) , etc
These email and Phone numbers are the most updated and verified contact information for Jungu Bae found in 2025.